Earnings Feed
Start Free
Nexvet Biopharma plc·4

Jul 1, 8:43 PM ET

Nexvet Biopharma plc 4

4 · Nexvet Biopharma plc · Filed Jul 1, 2016

Insider Transaction Report

Form 4
Period: 2016-07-01
Nexvet Biopharma plcNVET
Lismore Damian T.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2016-07-01−13,750→ 41,250 total
    Exercise: $0.13Exp: 2020-07-01→ Ordinary Shares (13,750 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2016-07-01$0.13/sh+13,750$1,719→ 33,750 total
  • Exercise/Conversion

    Ordinary Shares

    2016-07-01$0.13/sh+4,000$500→ 20,000 total
  • Exercise/Conversion

    Option to Purchase Shares

    2016-07-01−4,000→ 4,000 total
    Exercise: $0.13Exp: 2019-07-01→ Ordinary Shares (4,000 underlying)
Holdings

  • Ordinary Shares

    (indirect: By Spouse)
    14,160

  • Ordinary Shares

    (indirect: Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C>)
    18,724
Footnotes (3)
  • [F1]The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
  • [F2]The remaining 4,000 options will vest and become exercisable on 7/1/17.
  • [F3]13,750 of the Restricted Share Units shall vest and become convertible on each of 7/1/17, 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT